Large hospitals waiting for the launch of the new obesity drug ‘Belviq’

The new obesity drug, ‘Belviq,’ has been exceptionally noticeable among doctors.

Belviq has attracted doctors as a new obesity drug, which would be first launched since the last obesity drug in 13 years. Shinhan Investment Corp. confirmed the distribution quantity of Belviq at KRW 5.3 billion in the first quarter of the year, and anticipated sales of the year at KRW 12.6 billion.

Large-sized ...